Stago - Homepage Stago AU

Our Products & Services

NEW: STA®-Liatest® D-Di Plus, Less interferences for even More Confidence

As part of Stago's continuous improvement commitment, STA® -Liatest® D-Di Plus* was developed as an evolution of the STA® -Liatest® D-Di, on...

In STA® -Liatest® D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including...

STA Compact Max®: Innovation born from Expertise

STA Compact Max® is the new generation of analyser developed by the Coagulation Company to meet labs' expectations.

The Compact STA Max® is a genuine synthesis of Stago's know-how and possesses the main qualities of a Haemostasis system that you are entitled to expect.

Max Reliability

...

New range of STA®-Routine QC quality control plasmas: The best range for routine laboratory tests

To fulfil regulatory requirements, laboratories must perform regular internal quality control (IQC) on at least two concentration levels (no...

Assayed (titrated) IQC plasmas are used to evaluate the precision and accuracy of the reagent-analyser combination and therefore to ensure the reliability of your patients’ results.

Stago’s new...

STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control (CE marked)

Rivaroxaban is a new oral anticoagulant, direct factor Xa inhibitor, developed by Bayer HealthCare and sold under the trade name Xarelto®. ...

In the US, Xarelto is approved for stroke prevention in AF patients and prevention of VTE in hip or knee surgery.
In total, Rivaroxaban is approved in more than 110 countries worldwide. This makes...

STic Expert® HIT

For every Heparin Induced Thrombocytopenia (HIT) suspicion. A rapid and specific exclusion of Heparin Induced Thrombocytopenia in 10 minute...

Patients with HIT have a very high thrombosis risk. They require alternative anticoagulant treatments which increase the bleeding risk. In the absence of a rapid and reliable laboratory assay, many...

Our Strengths

Stago in Australia/New Zealand

Stago is the market leader in the supply of Haemostasis products within the ANZ market.

Our ANZ head office and training facilities are located in Doncaster, and we have a presence in most states of Australia and both islands in New Zealand.

Our team is highly specialised, and able to support you in the field of Haemostasis.

Our Commitment

Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related pathologies.

Events

October 28 - 31, 2012
Annual Scientific Meeting of the HAA 2012

August 20 - 23, 2013
New Zealand Institute of Medical Laboratory Science ASM

All Events

IPad app

This Ouvre un lien externe dans la fenêtre courante free educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.

Understanding Haemostasis

What is Haemostasis?

Did you know?

In 1953, Dr R. Langdell et al. proposed a plasma clotting test that could be used for assaying antihaemophilic factor. They designated their one-stage test as "partial thromboplastin time".

Careers

Recent Jobs

Sorry, we don't have any job openings at the moment. Please check back later.

Apply

Submit Application Enquiries